DaVita
DVA
#2033
Rank
HK$79.78 B
Marketcap
HK$1,193
Share price
2.03%
Change (1 day)
5.20%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$78.92

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$79.18. In 2024 the company made an earnings per share (EPS) of HK$86.30 an increase over its 2023 EPS that were of HK$59.54.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$78.92-8.55%
2024HK$86.3044.94%
2023HK$59.5427.26%
2022HK$46.79-35.56%
2021HK$72.6144.1%
2020HK$50.3919.7%
2019HK$42.09540.48%
2018HK$6.57-76.07%
2017HK$27.46-19.31%
2016HK$34.03242.52%
2015HK$9.94-62.87%
2014HK$26.7613.43%
2013HK$23.598.45%
2012HK$21.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$167.04 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$80.20 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$115.01 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.86-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA